Picture EBD Group ChinaBio Partnering Forum 2025 Shanghai 650x100px

Organisation › Details

Johnson & Johnson Inc. (NYSE: JNJ) (JnJ)

https://www.jnj.com

	Start	1990-01-01 existent
	Group	Johnson & Johnson (JnJ) (Group)
	Industry	pharmaceutical
	Industry 2	diagnostics (medical/biological)
	Person	Gorsky, Alex (JnJ 201701 CEO before 200811 Group Chairman for Ethicon business worldwide)

	Region	New Brunswick, NJ
	Country	United States (USA)
	Street	One Johnson & Johnson Plaza
	City	08933 New Brunswick, NJ
		Address record changed: 2020-12-02

Basic data	Employees	J: more than 100,0 (2017-01-26)
	Currency	USD
	Annual sales	82,584,000,000 (sales, consolidated (2020) 2020-12-31)


		Record changed: 2025-04-20

Picture EBD Group ChinaBio Partnering Forum 2025 Shanghai 650x200px

More documents for Johnson & Johnson (JnJ) (Group)

[1] Chromatin Bioscience Ltd.. (2/20/25). "Press Release: Chromatin Bioscience Joins JLABS EMEA". Edinburgh....
[2] Chromatin Bioscience Ltd.. (1/20/25). "Press Release (News): Chromatin Bioscience Signs a Research Collaboration with Johnson & Johnson"....
[3] Johnson & Johnson Inc.. (1/13/25). "Press Release: Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.". New Brunswick, NJ & Bedminster, NJ....
[4] Addex Therapeutics S.A.. (7/22/24). "Press Release: Addex’s Partner Discontinues ADX71149 Development in Epilepsy". Geneva....
[5] Bright Peak Therapeutics AG. (6/11/24). "Press Release: Bright Peak Therapeutics Announces $90 Million in Series C Financing to Advance First-in-Class PD1-IL18 Immunoconjugate Program Into Clinical Trials". Basel & San Diego, CA....
[6] Numab Therapeutics AG. (5/28/24). "Press Release: Numab Therapeutics Announces Johnson & Johnson to Acquire Its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-Specific Antibody for the Treatment of Atopic Dermatitis". H...
[7] Addex Therapeutics S.A.. (4/29/24). "Press Release: Addex Provides Update on ADX71149 Phase 2 Epilepsy Study". Geneva....
[8] Basel Area Business & Innovation. (4/26/24). "Press Release: Johnson & Johnson Opens Innovation Hub in Allschwil"....
[9] Recursion Pharmaceuticals, Inc.. (4/16/24). "Press Release: Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer". Salt Lake City, UT....
[10] Asgard Therapeutics AB. (3/14/24). "Press Release: Asgard Therapeutics Announces €30 Million Series A Financing to Advance Its First-in-Class in vivo Cell Reprogramming Platform for Immuno-oncology". Lund....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]